2017 Medicinal Chemistry Reviews
Case History: Epidaza® (Chidamide): A Novel Oral Histone Deacetylase Inhibitor with Subtype Selectivity for Cancer Treatment
Xian P. Lu, Zhi B. Li, Zhi Q. Ning, De S. Pan, Song Shan, Xia Guo, Hai X. Cao, Jin D. Yu, and Qian J. Yang
Ref. n°: REV2017-ch26
You must be connected to be able to download the pdf file of this chapter.